<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03032627</url>
  </required_header>
  <id_info>
    <org_study_id>TRIMDFH 936207</org_study_id>
    <nct_id>NCT03032627</nct_id>
  </id_info>
  <brief_title>Identifying Targets of Maladaptive Metabolic Responses in Heart Failure</brief_title>
  <official_title>Identifying Targets of Maladaptive Metabolic Responses in Heart Failure</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Translational Research Institute for Metabolism and Diabetes, Florida</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Florida Hospital Cardiovascular Institute</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Sanford-Burnham Medical Research Institute</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Translational Research Institute for Metabolism and Diabetes, Florida</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of the research is to help researchers understand changes in metabolism in
      patients that develop heart failure.
    </textblock>
  </brief_summary>
  <overall_status>Enrolling by invitation</overall_status>
  <start_date>December 2016</start_date>
  <completion_date type="Anticipated">August 2018</completion_date>
  <primary_completion_date type="Anticipated">August 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Analyses of collected tissues</measure>
    <time_frame>Restricted to the time around surgical procedure</time_frame>
    <description>Tissue samples collected during surgery will be analyzed by way of immunoblot and qrtPCR of mRNA for metabolic enzymes on neutralized acid extracts.</description>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">165</enrollment>
  <condition>Heart Failure</condition>
  <arm_group>
    <arm_group_label>Cardiac surgery</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Subjects will be recruited by a coordinator through electronic medical record (EMR) searches to identify those undergoing left ventricle assist device (LVAD) implantation and explantation, heart transplant, valve replacement or repair, endomyocardial biopsy during catheterization, and arterial bypass surgery. Prior to the procedure, potential subjects will be informed about the clinical study and if interested, they will be consented.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Collection of discarded heart tissue</intervention_name>
    <description>Discarded heart tissue will be collected from patients undergoing the aforementioned cardiac surgeries.</description>
    <arm_group_label>Cardiac surgery</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Subjects are capable of giving informed consent.

          2. Age 19-89

          3. Diagnosis of chronic heart failure

          4. Any patients scheduled for at least one of the following procedures:

               1. LVAD implantation or as recipient for cardiac transplantation.

               2. LVAD placement both as bridge to transplant and as destination therapy.

               3. LVAD explantation

               4. Valve replacement or repair

               5. Catheterization and myocardial biopsy for idiopathic cardiomyopathy

               6. Coronary artery bypass graft (CABG)

        Exclusion Criteria:

          1. Life expectancy less than 2 weeks

          2. Diagnosed with following co-morbidities: cancer, chronic kidney disease (GFR≤30 or
             serum creatinine &gt;2.1), active infection or treatment with antibiotics or persistent
             infectious disease (hepatitis, HIV, etc), cirrhosis, active substance abuse and/or
             alcohol dependence (≥ 14 alcoholic beverages per week).

        Control Myocardial Tissue from Donor Hearts Inclusion Criteria

          1. Samples collected from non-failing hearts deemed unsuitable for transplantation by
             TransLife because of either acute recipient issues or post-harvest evidence of
             pathology or positive but benign serology.

          2. Normal cardiac function from medical records

        Exclusion Criteria:

          1. Pathological remodeling and extensive infarction with limited non-pathological regions
             of myocardium.

          2. Abnormal or impaired cardiac function from medical records, which are self
             determinants for rejection as a donor organ.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>19 Years</minimum_age>
    <maximum_age>89 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Richard E Pratley, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Translational Research Institute for Metabolism and Diabetes</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Translational Research Institute for Metabolism and Diabetes</name>
      <address>
        <city>Orlando</city>
        <state>Florida</state>
        <zip>32804</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <reference>
    <citation>Braunwald E. Heart failure. JACC Heart Fail. 2013 Feb;1(1):1-20. doi: 10.1016/j.jchf.2012.10.002. Epub 2013 Feb 4. Review.</citation>
    <PMID>24621794</PMID>
  </reference>
  <reference>
    <citation>Franklyn JA. The molecular mechanisms of thyroid hormone action. Baillieres Clin Endocrinol Metab. 1988 Nov;2(4):891-909. Review.</citation>
    <PMID>2908318</PMID>
  </reference>
  <reference>
    <citation>Grosjean O, Bluemenstock D. [Pulmonary and renal transplantations in the dog treated by single and later repeated neonatal injections of bone marrow]. C R Seances Soc Biol Fil. 1967 Sep;161(3):733-7. French.</citation>
    <PMID>4229424</PMID>
  </reference>
  <reference>
    <citation>Heath DF. Subcellular aspects of the response to trauma. Br Med Bull. 1985 Jul;41(3):240-5. Review.</citation>
    <PMID>3896379</PMID>
  </reference>
  <reference>
    <citation>Ingwall JS, Weiss RG. Is the failing heart energy starved? On using chemical energy to support cardiac function. Circ Res. 2004 Jul 23;95(2):135-45. Review.</citation>
    <PMID>15271865</PMID>
  </reference>
  <reference>
    <citation>Suyama K, Goldstein J, Aebersold R, Kent S. Regarding the size of Rh proteins. Blood. 1991 Jan 15;77(2):411.</citation>
    <PMID>1898705</PMID>
  </reference>
  <reference>
    <citation>Blahos J, Mertl L, Gregor O, Kotas J, Reisenauer R. [Stimulating effect of hypercalcaemia on basal gastric secretion (author's transl)]. Cas Lek Cesk. 1974 Aug 2;113(31):944-7. Czech.</citation>
    <PMID>4410983</PMID>
  </reference>
  <reference>
    <citation>Bucci E, Mignogna MD. [Diagnosis and prevention of stress in dental patients]. Dent Cadmos. 1986 May 31;54(9):77-8, 80, 82. Italian.</citation>
    <PMID>3464497</PMID>
  </reference>
  <reference>
    <citation>Török B. Microcomputer-based recording system for clinical electrophysiology. Doc Ophthalmol. 1990 Sep;75(2):189-97.</citation>
    <PMID>2276319</PMID>
  </reference>
  <reference>
    <citation>Polak J, Kotrc M, Wedellova Z, Jabor A, Malek I, Kautzner J, Kazdova L, Melenovsky V. Lipolytic effects of B-type natriuretic peptide 1-32 in adipose tissue of heart failure patients compared with healthy controls. J Am Coll Cardiol. 2011 Sep 6;58(11):1119-25. doi: 10.1016/j.jacc.2011.05.042.</citation>
    <PMID>21884948</PMID>
  </reference>
  <reference>
    <citation>Collins S. A heart-adipose tissue connection in the regulation of energy metabolism. Nat Rev Endocrinol. 2014 Mar;10(3):157-63. doi: 10.1038/nrendo.2013.234. Epub 2013 Dec 3. Review.</citation>
    <PMID>24296515</PMID>
  </reference>
  <reference>
    <citation>Kovacova Z, Tharp WG, Liu D, Wei W, Xie H, Collins S, Pratley RE. Adipose tissue natriuretic peptide receptor expression is related to insulin sensitivity in obesity and diabetes. Obesity (Silver Spring). 2016 Apr;24(4):820-8. doi: 10.1002/oby.21418. Epub 2016 Feb 17.</citation>
    <PMID>26887289</PMID>
  </reference>
  <verification_date>February 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>January 17, 2017</study_first_submitted>
  <study_first_submitted_qc>January 23, 2017</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 26, 2017</study_first_posted>
  <last_update_submitted>February 13, 2018</last_update_submitted>
  <last_update_submitted_qc>February 13, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">February 14, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Heart Failure</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

